Real-World Quantitative Insights into the Treatment Experience of Patients with Cancer in the USA with Subcutaneous Versus Intravenous Drug Delivery

To our knowledge, this study was the first in the USA to survey real-world treatment preferences of patients with cancer experienced with both SC- and IV-delivered care. Findings demonstrated a strong overall preference towards SC delivery, providing valuable insights and highlighting the need to broaden treatment considerations to include patient perspectives.